Intelligence exchange platform for passionate healthcare executives; promoting an invigorating dialogue on healthcare
Johnson & Johnson last year enrolled 45,000 patients into a phase three clinical trial for its vaccine candidate. Those patients are still being monitored.
Johnson & Johnson last year enrolled 45,000 patients into a phase three clinical trial for its vaccine candidate. Those patients are still being monitored.
Expand your knowledge of healthcare issues and learn from other innovators.
Connect and interact with other healthcare thought leaders.
Rate the content on the site that you approve/disapprove.
Contribute your experience and knowledge (articles, photos, videos).
